MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 68 filers reported holding MIRATI THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $1,029,000 | +26.3% | 32,566 | +25.7% | 0.13% | +14.9% |
| Q2 2015 | $815,000 | +149.2% | 25,900 | +131.2% | 0.11% | +147.8% |
| Q1 2015 | $327,000 | +41.6% | 11,200 | -3.4% | 0.05% | +35.3% |
| Q2 2014 | $231,000 | -70.5% | 11,600 | -71.9% | 0.03% | -72.1% |
| Q1 2014 | $784,000 | +271.6% | 41,300 | +223.8% | 0.12% | +229.7% |
| Q4 2013 | $211,000 | – | 12,755 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aviva Holdings Ltd. | 3,135,966 | $136,602,679 | 87.83% |
| EcoR1 Capital, LLC | 5,748,399 | $250,400,260 | 8.45% |
| Boxer Capital, LLC | 3,201,440 | $139,454,726 | 7.42% |
| RTW INVESTMENTS, LP | 6,768,514 | $294,836,470 | 6.22% |
| Paradigm Biocapital Advisors LP | 1,668,116 | $72,663,133 | 4.93% |
| Avoro Capital Advisors LLC | 6,666,666 | $290,399,971 | 4.53% |
| Octagon Capital Advisors LP | 655,051 | $28,534,022 | 4.38% |
| Artal Group S.A. | 2,024,226 | $88,175 | 3.78% |
| Ally Bridge Group (NY) LLC | 70,283 | $3,061,527 | 3.59% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 216,000 | $9,404,640 | 3.17% |